Keyphrases
TP53 mutation
100%
Primary Breast Cancer
100%
Polo-like Kinase 1 (PLK1)
100%
Poor Clinical Outcomes
100%
Immunofluorescence Assay
100%
Breast Cancer
13%
Murine Double Minute 2 (MDM2)
13%
Clinical Outcomes
6%
Tumor
6%
Clinical Data
6%
Cultured Cells
6%
Protein Expression
6%
DNA Damage
6%
Cell Cycle Progression
6%
Negative Regulator
6%
Immunohistochemistry
6%
Poor Prognosis
6%
Chromatin Remodeling
6%
Tumor Samples
6%
Women with Breast Cancer
6%
Mutant p53
6%
Ki-67
6%
Tissue Microarray
6%
Pathology Report
6%
Primary Breast Tumor
6%
TP53 Gene
6%
Targeted Drugs
6%
Triple-negative Tumor
6%
Medicine and Dentistry
Breast Cancer
100%
Polo Like Kinase 1
100%
Protein P53
46%
Neoplasm
20%
Breast Tumor
6%
Protein Expression
6%
Immunohistochemistry
6%
Downregulation
6%
Cell Cycle Progression
6%
Tissue Microarray
6%
DNA Damage Response
6%
Chromatin Remodeling
6%
Biochemistry, Genetics and Molecular Biology
Polo-Like Kinase 1
100%
P53
46%
Protein Expression
6%
DNA Damage Response
6%
Downregulation
6%
Chromatin Remodeling
6%
Cell Cycle Progression
6%
Tissue Microarray
6%